Sofiva Genomics Co.,Ltd. (6615.TWO)
TWD 32.65
(-4.81%)
TWD 32.65
(-4.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 23.69 Million | 17.13 Million | 80.06 Million | 60.82 Million | - |
| Net Income | 8.9 Million | 47.34 Million | 63.69 Million | 37.27 Million | - |
| Depreciation & Amortization | 41.34 Million | 42.79 Million | 41.95 Million | 48.16 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.07 Million | 2.67 Million | 2.86 Million | 1.87 Million | - |
| Change in working capital | -2.65 Million | -25.71 Million | 7.88 Million | 7.55 Million | - |
| Other non-cash items | -167 Thousand | 817 Thousand | 1.39 Million | 1.55 Million | - |
| Investing Cash Flow | -9.98 Million | -53.48 Million | -10.02 Million | -46.38 Million | - |
| Investments in PPE | -24.55 Million | -35.69 Million | -12.65 Million | -15.91 Million | - |
| Acquisitions | -567 Thousand | - | - | - | -79.25 Million |
| Investment purchases | - | -20.95 Million | - | -30.2 Million | - |
| Sales/Maturities of investments | 7.92 Million | - | - | - | - |
| Other Investing Activities | -2.25 Million | -2.86 Million | -1.82 Million | -267 Thousand | - |
| Financing Cash Flow | -36.66 Million | -58.65 Million | -44.19 Million | -70.04 Million | - |
| Debt repayment | -14.74 Million | - | - | - | -400 Thousand |
| Dividends payments | -21.36 Million | -42.72 Million | -29.76 Million | -55.17 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.11 Million | 548 Thousand | 739 Thousand |
| Other Financing Activities | -567 Thousand | -177 Thousand | -2000.00 | - | - |
| Accounts receivables | -918 Thousand | - | - | - | - |
| Accounts payables | -18.88 Million | - | - | - | - |
| Inventory | 15.29 Million | -15.51 Million | 8.54 Million | -15.83 Million | - |
| Other working capital | -17.03 Million | - | - | - | - |
| Cash at beginning of period | 119.81 Million | 214.99 Million | 188.84 Million | 244.95 Million | - |
| Cash at end of period | 96.8 Million | 119.81 Million | 214.99 Million | 188.84 Million | - |
| Capital Expenditure | -24.55 Million | -35.69 Million | -12.65 Million | -15.91 Million | - |
| Effect of forex changes on cash | -48 Thousand | -179 Thousand | 293 Thousand | -503 Thousand | - |
| Net cash flow / Change in cash | -23 Million | -95.18 Million | 26.14 Million | -56.11 Million | - |
| Free Cash Flow | -859 Thousand | -18.56 Million | 67.41 Million | 44.9 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.93 Million | 14.31 Million | 8.9 Million | -3.55 Million | 4.16 Million | 3.92 Million |
| Depreciation & Amortization | 10.43 Million | 10.08 Million | 41.34 Million | 10.34 Million | 10.75 Million | 10.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 397 Thousand | -1.15 Million | 1.07 Million | 190 Thousand | 350 Thousand | 409 Thousand |
| Change in working capital | 2.2 Million | -26.13 Million | -2.65 Million | 1.48 Million | -20.68 Million | 15.01 Million |
| Other non-cash items | -150 Thousand | -31 Thousand | -167 Thousand | -132 Thousand | 83 Thousand | -147 Thousand |
| Investing Cash Flow | -14.28 Million | -1.39 Million | -9.98 Million | -2.47 Million | -6.66 Million | 9.54 Million |
| Investments in PPE | -19.67 Million | -1.66 Million | -24.55 Million | -945 Thousand | -3.84 Million | -17.72 Million |
| Acquisitions | 13 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | -11.92 Million | 5.97 Million |
| Sales/Maturities of investments | 2 Million | 5.02 Million | 7.92 Million | - | -4 Million | 5.97 Million |
| Other Investing Activities | 3.37 Million | -4.75 Million | -2.25 Million | -1.52 Million | 1.17 Million | 12.39 Million |
| Financing Cash Flow | 1.82 Million | -4.4 Million | -36.66 Million | -3.91 Million | -25.05 Million | -3.57 Million |
| Debt repayment | -1.63 Million | - | - | - | - | - |
| Dividends payments | - | - | -21.36 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.7 Million | - | - | - | - | - |
| Other Financing Activities | -3.87 Million | -551 Thousand | -567 Thousand | - | - | - |
| Accounts receivables | 2.5 Million | - | - | - | - | - |
| Accounts payables | 1.53 Million | - | - | - | - | - |
| Inventory | -266 Thousand | -4.29 Million | 15.29 Million | 1.83 Million | -379 Thousand | 4.89 Million |
| Other working capital | 74 Thousand | - | - | - | - | - |
| Cash at beginning of period | 81.04 Million | 96.8 Million | 119.81 Million | 99.98 Million | 140.51 Million | 112.87 Million |
| Cash at end of period | 87.21 Million | 81.04 Million | 96.8 Million | 96.8 Million | 99.98 Million | 140.51 Million |
| Capital Expenditure | -19.67 Million | -1.66 Million | -24.55 Million | -945 Thousand | -3.84 Million | -17.72 Million |
| Effect of forex changes on cash | -10 Thousand | 74 Thousand | -48 Thousand | -85 Thousand | -4000.00 | 66 Thousand |
| Net cash flow / Change in cash | 6.17 Million | -15.76 Million | -23 Million | -3.17 Million | -40.53 Million | 27.63 Million |
| Free Cash Flow | -1.03 Million | -11.7 Million | -859 Thousand | 2.35 Million | -12.65 Million | 3.88 Million |
7713
RNW
6294
THL
9927
1037